Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome

Articolo
Data di Pubblicazione:
2018
Citazione:
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome / Scumaci, D.; Oliva, A.; Concolino, A.; Curcio, A.; Fiumara, C. V.; Tamme, L.; Campuzano, O.; Pascali, V. L.; Coll, M.; Iglesias, A.; Berne, P.; Casu, G.; Olivo, E.; Ausania, F.; Ricci, P.; Indolfi, C.; Brugada, J.; Brugada, R.; Cuda, G.. - In: PROTEOMICS. CLINICAL APPLICATIONS. - ISSN 1862-8346. - 12:6(2018). [10.1002/prca.201800065]
Abstract:
Purpose: The Brugada syndrome (BrS) is a severe inherited cardiac disorder. Given the high genetic and phenotypic heterogeneity of this disease, three different “omics” approaches are integrated in a synergic way to elucidate the molecular mechanisms underlying the pathophysiology of BrS as well as for identifying reliable diagnostic/prognostic markers. Experimental design: The profiling of plasma Proteome and MiRNome is perfomed in a cohort of Brugada patients that were preliminary subjected to genomic analysis to assess a peculiar gene mutation profile. Results: The integrated analysis of “omics” data unveiled a cooperative activity of mutated genes, deregulated miRNAs and proteins in orchestrating transcriptional and post-translational events that are critical determining factors for the development of the Brugada pattern. Conclusions and clinical relevance: This study provides the basis to shed light on the specific molecular fingerprints underlying BrS development and to gain further insights on the pathogenesis of this life-threatening cardiac disease.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
brugada syndrome; genomics; MiRNA; personalized medicine; proteomics; reactive oxygen species
Elenco autori:
Scumaci, D.; Oliva, A.; Concolino, A.; Curcio, A.; Fiumara, C. V.; Tamme, L.; Campuzano, O.; Pascali, V. L.; Coll, M.; Iglesias, A.; Berne, P.; Casu, G.; Olivo, E.; Ausania, F.; Ricci, P.; Indolfi, C.; Brugada, J.; Brugada, R.; Cuda, G.
Autori di Ateneo:
CASU Gavino
Link alla scheda completa:
https://iris.uniss.it/handle/11388/323876
Pubblicato in:
PROTEOMICS. CLINICAL APPLICATIONS
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0